IDEAYA Biosciences Inc (IDYA)
26.79
+0.19
(+0.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.77
-0.02
(-0.07%)
After-Hours: 20:00
IDEAYA Biosciences Free Cash Flow: -153.27M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -153.27M |
| June 30, 2024 | -134.36M |
| March 31, 2024 | -134.84M |
| December 31, 2023 | -117.59M |
| September 30, 2023 | -116.38M |
| June 30, 2023 | -110.87M |
| March 31, 2023 | -98.46M |
| December 31, 2022 | -90.62M |
| September 30, 2022 | -84.51M |
| June 30, 2022 | -72.17M |
| March 31, 2022 | -63.74M |
| December 31, 2021 | -58.42M |
| Date | Value |
|---|---|
| September 30, 2021 | -52.94M |
| June 30, 2021 | 49.96M |
| March 31, 2021 | 49.79M |
| December 31, 2020 | 54.97M |
| September 30, 2020 | 57.82M |
| June 30, 2020 | -42.77M |
| March 31, 2020 | -39.82M |
| December 31, 2019 | -40.67M |
| September 30, 2019 | -39.53M |
| June 30, 2019 | -38.59M |
| March 31, 2019 | -33.98M |
| December 31, 2018 | -29.33M |
Free Cash Flow Range, Past 5 Years
-153.27M
Minimum
Sep 2024
57.82M
Maximum
Sep 2020
-59.94M
Average
-67.96M
Median
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 9.431B |
| Vertex Pharmaceuticals Inc | -1.352B |
| Black Diamond Therapeutics Inc | -61.20M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.23M |
| Cash from Investing (Quarterly) | -20.04M |
| Cash from Financing (Quarterly) | 286.50M |
| Free Cash Flow Per Share (Quarterly) | -0.5765 |
| Free Cash Flow Yield | -7.51% |